Terumo Blood and Cell Technologies

QUICK LINKS

Get Product Support Find Technical Documents Find Certificates of Compliance Get Training Start a Career With Us Distributor News Modern Slavery Act Statement Community Letter - Ethylene Oxide (EtO)

LATEST NEWS

Terumo Blood and Cell Technologies collaborates with MCQ to enable automated gas mixing for expansion of cell and gene therapies

Bark and Brew 5K Fun Run and Walk For a Cure

Terumo Blood and Cell Technologies’ Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use

Terumo Blood and Cell Technologies Appoints Veerle d'Haenens as General Manager, Cell Therapy Technologies.

Terumo Blood and Cell Technologies Presents First Quantum Flex Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose

IMUGARD^® WB Platelet Pooling Set cleared by FDA, officially launched.

Donation to Blood Emergency Readiness Corps Supports an Adequate U.S. Blood Supply

Terumo Blood and Cell Technologies launches Quantum Flex bioreactor platform, one of the first systems that enables cell therapy commercialization from process development through manufacturing

Rika Plasma Donation System Reaches Critical Milestone with Plasma Collection from First Donor

Collaboration with Eliaz Therapeutics in the development of a novel therapeutic apheresis treatment for acute kidney injury (AKI)

{{$index+1}}. {{s.label}}

908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System

Proven therapy can help thousands more patients with rare diseases – if they can access it

Terumo Blood and Cell Technologies launches study with BioCentriq^® to generate public CAR-T cell data using Terumo BCT’s CGT manufacturing platforms

Terumo Blood and Cell Technologies Appoints Jackie Kunzler to Head Research and Development.

Terumo Blood and Cell Technologies’ Reveos^® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use. Read more.

From humble roots to CEO, changing global healthcare one step at a time
Watch now.

Terumo Blood and Cell Technologies Optimizing Cell Therapy Production Through Industry’s First Apheresis Training for Cell Therapy Manufacturers
Read More.

Terumo Blood and Cell Technologies Appoints Veerle d'Haenens as General Manager, Cell Therapy Technologies.
Read More.

Quantum Flex^® Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose

LATEST NEWS

Terumo Blood and Cell Technologies collaborates with MCQ to enable automated gas mixing for expansion of cell and gene therapies

Bark and Brew 5K Fun Run and Walk For a Cure

Terumo Blood and Cell Technologies’ Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use

Terumo Blood and Cell Technologies Appoints Veerle d'Haenens as General Manager, Cell Therapy Technologies.

Terumo Blood and Cell Technologies Presents First Quantum Flex Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose

IMUGARD^® WB Platelet Pooling Set cleared by FDA, officially launched.

Donation to Blood Emergency Readiness Corps Supports an Adequate U.S. Blood Supply

Terumo Blood and Cell Technologies launches Quantum Flex bioreactor platform, one of the first systems that enables cell therapy commercialization from process development through manufacturing

Rika Plasma Donation System Reaches Critical Milestone with Plasma Collection from First Donor

Collaboration with Eliaz Therapeutics in the development of a novel therapeutic apheresis treatment for acute kidney injury (AKI)

908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System

Proven therapy can help thousands more patients with rare diseases – if they can access it

Terumo Blood and Cell Technologies launches study with BioCentriq® to generate public CAR-T cell data using Terumo BCT’s CGT manufacturing platforms

Terumo Blood and Cell Technologies Appoints Jackie Kunzler to Head Research and Development.

Terumo Blood and Cell Technologies’ Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use. Read more.

From humble roots to CEO, changing global healthcare one step at a time Watch now.

Terumo Blood and Cell Technologies Optimizing Cell Therapy Production Through Industry’s First Apheresis Training for Cell Therapy Manufacturers Read More.

Terumo Blood and Cell Technologies Appoints Veerle d'Haenens as General Manager, Cell Therapy Technologies. Read More.

Quantum Flex® Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose

LATEST NEWS

Terumo Blood and Cell Technologies collaborates with MCQ to enable automated gas mixing for expansion of cell and gene therapies

Bark and Brew 5K Fun Run and Walk For a Cure

Terumo Blood and Cell Technologies’ Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use

Terumo Blood and Cell Technologies Appoints Veerle d'Haenens as General Manager, Cell Therapy Technologies.

Terumo Blood and Cell Technologies Presents First Quantum Flex Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose

IMUGARD® WB Platelet Pooling Set cleared by FDA, officially launched.

Donation to Blood Emergency Readiness Corps Supports an Adequate U.S. Blood Supply

Terumo Blood and Cell Technologies launches Quantum Flex bioreactor platform, one of the first systems that enables cell therapy commercialization from process development through manufacturing

Rika Plasma Donation System Reaches Critical Milestone with Plasma Collection from First Donor

Collaboration with Eliaz Therapeutics in the development of a novel therapeutic apheresis treatment for acute kidney injury (AKI)

Terumo Blood and Cell Technologies launches study with BioCentriq^® to generate public CAR-T cell data using Terumo BCT’s CGT manufacturing platforms

Terumo Blood and Cell Technologies’ Reveos^® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use. Read more.

From humble roots to CEO, changing global healthcare one step at a time
Watch now.

Terumo Blood and Cell Technologies Optimizing Cell Therapy Production Through Industry’s First Apheresis Training for Cell Therapy Manufacturers
Read More.

Terumo Blood and Cell Technologies Appoints Veerle d'Haenens as General Manager, Cell Therapy Technologies.
Read More.

Quantum Flex^® Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose

IMUGARD^® WB Platelet Pooling Set cleared by FDA, officially launched.